Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 97,200 | 44,800 | 183,300 | 166,100 | 140,400 |
| Depreciation Amortization | 179,900 | 79,600 | 281,900 | 204,400 | 133,400 |
| Income taxes - deferred | -43,900 | -3,200 | -118,300 | -75,700 | -26,900 |
| Accounts receivable | -231,900 | 30,100 | -57,100 | -12,200 | 3,100 |
| Other Working Capital | -24,100 | 62,900 | 88,900 | -13,500 | -80,300 |
| Other Operating Activity | 314,600 | 17,800 | 192,300 | 53,500 | 16,400 |
| Operating Cash Flow | $291,800 | $232,000 | $571,000 | $322,600 | $186,100 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,200 | 800 | 104,900 | 4,000 | 3,000 |
| PPE Investments | -40,700 | -19,300 | -53,900 | -31,300 | -14,200 |
| Net Acquisitions | -561,100 | N/A | -67,500 | -67,400 | -16,800 |
| Purchase Of Investment | N/A | -1,000 | -49,200 | -13,700 | -17,100 |
| Sale Of Investment | N/A | N/A | N/A | 94,700 | 94,600 |
| Purchase Sale Intangibles | -10,200 | N/A | -10,900 | -7,400 | -7,100 |
| Other Investing Activity | -9,600 | 0 | -8,400 | -6,400 | -6,100 |
| Investing Cash Flow | $-609,200 | $-19,500 | $-74,100 | $-20,100 | $43,400 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 250,000 | N/A | N/A | 0 | 0 |
| Debt Repayment | -28,800 | N/A | -459,700 | -274,600 | -224,300 |
| Common Stock Issued | 42,600 | 20,300 | 54,700 | 32,500 | 25,500 |
| Common Stock Repurchased | -11,100 | -10,300 | -6,300 | -5,700 | -4,600 |
| Other Financing Activity | 4,400 | 1,200 | 0 | 0 | 0 |
| Financing Cash Flow | $257,100 | $11,200 | $-411,300 | $-247,800 | $-203,400 |
| Exchange Rate Effect | 2,600 | -2,000 | -4,200 | -500 | -2,700 |
| Beginning Cash Position | 282,800 | 282,800 | 201,400 | 201,400 | 201,400 |
| End Cash Position | 225,100 | 504,500 | 282,800 | 255,600 | 224,800 |
| Net Cash Flow | $-57,700 | $221,700 | $81,400 | $54,200 | $23,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 291,800 | 232,000 | 571,000 | 322,600 | 186,100 |
| Capital Expenditure | -41,500 | -19,300 | -56,600 | -33,600 | -16,500 |
| Free Cash Flow | 250,300 | 212,700 | 514,400 | 289,000 | 169,600 |